Skip to main content
. 2007 May 8;96(11):1675–1683. doi: 10.1038/sj.bjc.6603779

Figure 1.

Figure 1

CYP26 induction in a panel of neuroblastoma cell lines. Reverse-transcribed RNA from neuroblastoma cells treated with 0.1 μM ATRA (A) or 13cisRA (B) for 24 h was subjected to real-time PCR using TaqMan probes for CYP26A1, CYP26B1 and β-actin. Values are normalised for β-actin levels and expressed as fold increase relative to expression of CYP26 in SH-SY5Y cells treated with 0.01 μM ATRA. Data are mean values±s.e.m. (n⩾3).